Efficacy and tolerance of infliximab in refractory Takayasu arteritis: French multicentre study.
about
Outcome assessment in Takayasu arteritisThe role of biological agents in the management of large vessel vasculitis (LVV): a systematic review and meta-analysisTNF inhibitors appear to inhibit disease progression and improve outcome in Takayasu arteritis; an observational, population-based time trend study.Anti-cytokine treatment for Takayasu arteritis: State of the artIntravascular immunity as a key to systemic vasculitis: a work in progress, gaining momentum.Takayasu Arteritis With Antiphosphatidylserine/Prothrombin Antibody-Positive Antiphospholipid Syndrome: Case Report and Literature Review.Tumor necrosis factor alpha inhibitors in patients with Takayasu's arteritis refractory to standard immunosuppressive treatment: cases series and review of the literature.Clinical diagnosis and management of large vessel vasculitis: Takayasu arteritis.[Childhood vasculitis].Remission achieved in refractory advanced takayasu arteritis using rituximab.Development and initial validation of the Indian Takayasu Clinical Activity Score (ITAS2010).Takayasu arteritis developing during treatment of ulcerative colitis with infliximab.Childhood Takayasu arteritis: disease course and response to therapy.Clinical interventions for Takayasu arteritis: A systematic review.Efficacy and safety of tocilizumab in patients with refractory Takayasu arteritis: results from a randomised, double-blind, placebo-controlled, phase 3 trial in Japan (the TAKT study).Infliximab biosimilar CT-P13 therapy in patients with Takayasu arteritis with low dose of glucocorticoids: a prospective single-arm study
P2860
Q26782601-6734E70A-112B-4C65-8387-146F9A0900BBQ26853258-A14AFEDA-AAFC-4EA1-9587-5D49E6F356A1Q33706285-6DD83755-D6EC-4448-A21B-F37B4663C1A5Q34377764-93A41B36-D0B4-4DD1-8575-D52FBA68A3EFQ34377832-7CF0F60D-4E2F-46A1-A51E-0EE6CC355532Q36421084-214BA31D-9C73-4B50-A01A-C21CE559C97BQ38133360-163538D4-61E5-41BE-A4CB-540A0B1B8E3DQ38217342-38819B93-A378-4D24-8292-BBF57EA23E1CQ40898755-60F205A9-8811-45C3-8D1B-D3924D3D9C40Q41846985-13BA7274-B3F1-4A75-84CF-705D64C601CEQ43487270-AE2695AE-F6C7-41DC-B034-4D225691818FQ44857287-F437A420-8E7C-47F6-A153-25E1B27B813DQ47165426-5DF3B494-C606-48D7-B7E2-D21877D5BA8AQ47998169-083DF891-0726-48AD-843B-6093165F1884Q49388173-C2317733-F40B-4167-BCDB-9C661979DD09Q59130566-2498F6DF-F320-48ED-9283-9594EED43FC5
P2860
Efficacy and tolerance of infliximab in refractory Takayasu arteritis: French multicentre study.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Efficacy and tolerance of infl ...... tis: French multicentre study.
@en
Efficacy and tolerance of infl ...... tis: French multicentre study.
@nl
type
label
Efficacy and tolerance of infl ...... tis: French multicentre study.
@en
Efficacy and tolerance of infl ...... tis: French multicentre study.
@nl
prefLabel
Efficacy and tolerance of infl ...... tis: French multicentre study.
@en
Efficacy and tolerance of infl ...... tis: French multicentre study.
@nl
P2093
P2860
P356
P1433
P1476
Efficacy and tolerance of infl ...... itis: French multicentre study
@en
P2093
Arsène Mekinian
Bertrand Godeau
Club Rhumatismes et Inflammati ...... Française de Médecine Interne
Isabelle Marie
Jean Sibilia
Jean-Noel Fiessinger
Jérome Connault
Laure Federici
Loïc Guillevin
Mohamed Hamidou
P2860
P304
P356
10.1093/RHEUMATOLOGY/KER380
P577
2012-01-05T00:00:00Z